A. Menter, “Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial”, J of Skin, vol. 2, no. S1, p. S9, Feb. 2018.